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Direct interaction of beta-amyloid 
with Na,K-ATPase as a putative 
regulator of the enzyme function
Irina Yu. Petrushanko1,*, Vladimir A. Mitkevich1,*, Anastasia A. Anashkina1, Alexei A. Adzhubei1, 
Ksenia M. Burnysheva1, Valentina A. Lakunina1, Yulia V. Kamanina1, Elena A. Dergousova1, 
Olga D. Lopina2, Omolara O. Ogunshola3, Anna Yu. Bogdanova3 & Alexander A. Makarov1
By maintaining the Na+ and K+ transmembrane gradient mammalian Na,K-ATPase acts as a key 
regulator of neuronal electrotonic properties. Na,K-ATPase has an important role in synaptic 
transmission and memory formation. Accumulation of beta-amyloid (Aβ) at the early stages of 
Alzheimer’s disease is accompanied by reduction of Na,K-ATPase functional activity. The molecular 
mechanism behind this phenomenon is not known. Here we show that the monomeric Aβ(1-42) forms a 
tight (Kd of 3 μM), enthalpy-driven equimolar complex with α1β1 Na,K-ATPase. The complex formation 
results in dose-dependent inhibition of the enzyme hydrolytic activity. The binding site of Aβ(1-42) is 
localized in the “gap” between the alpha- and beta-subunits of Na,K-ATPase, disrupting the enzyme 
functionality by preventing the subunits from shifting towards each other. Interaction of Na,K-ATPase 
with exogenous Aβ(1-42) leads to a pronounced decrease of the enzyme transport and hydrolytic 
activity and Src-kinase activation in neuroblastoma cells SH-SY5Y. This interaction allows regulation of 
Na,K-ATPase activity by short-term increase of the Aβ(1-42) level. However prolonged increase of Aβ(1-
42) level under pathological conditions could lead to chronical inhibition of Na,K-ATPase and disruption 
of neuronal function. Taken together, our data suggest the role of beta-amyloid as a novel physiological 
regulator of Na,K-ATPase.
Na,K-ATPase creates the Na+ and K+ transmembrane gradient vital for all animal cells, it also is a receptor for 
cardiotonic steroids, regulating cell proliferation and apoptosis. Na,K-ATPase in neurons consumes up to 80% 
of ATP, since it not only sustains the Na+, K+ gradient, but generates the action potential, maintaining the cell 
electrotonic characteristics1. Disruption of ion homeostasis and osmotic balance may hinder the normal electro-
tonic properties of dendrites by blocking intracellular signaling and contributing to degeneration of neurons2. 
Malfunction of Na,K-ATPase underlies a series of pathologies, such as ischemic tissue damage, cancer and neu-
rodegenerative diseases, such as Alzheimer’s disease (AD). AD is the most widely occurring neurodegenerative 
disease and is diagnosed in approximately 11% of population older than 65 years and 32% older than 85 years. A 
therapeutic strategy aimed at increasing the activity of Na,K-ATPase in AD was proposed as symptomatic relief 
and slowing down the progression of the disease2,3.
Development of AD is accompanied by the decreased activity of Na,K-ATPase2–5, while the causal link 
between the two phenomena has not yet been established. In the presence of beta-amyloid (Aβ ), a major com-
ponent of the amyloid plaques formed in AD, the Na,K-ATPase activity in the postmortem brain tissue samples 
from AD patients is reduced in contrast with the samples from age-matched control4; similar correlation was 
made for the samples from hippocampus and the microsomal fraction of brain tissue of transgenic mice and 
rats which showed memory deficiencies characteristic of AD5. Importantly, reduced activity of Na,K-ATPase 
was observed only in the areas of the brain where amyloid plaques were formed, i.e. in the hippocampus, but not 
in the plaques-free cerebellum2, suggesting possibility of a direct regulation of the Na,K-ATPase activity by Aβ .
Beta-amyloid (Aβ ) is a 36 to 43 amino acids long product of the amyloid precursor protein (APP) hydrolysis6, 
while the 40 and 42 a.a. peptides constitute the main fraction. Aβ in mammals was suggested to be an important 
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factor in the facilitating neuronal growth, cellular survival, the modulation of synaptic function and defense 
against oxidative stress7. The physiological concentrations of Aβ benefit learning and memory processes8, how-
ever its precise function has not been elucidated until now. Experiments on neuronal cell cultures indicated that 
at submicromolar concentrations Aβ affects cell differentiation, while at micromolar concentrations Aβ has a 
cytotoxic effect9. Recently it has been shown that amilospheroids, the neurotoxic 10–15-nm spherical Aβ oli-
gomers derived from AD-patients, target neuronal Na,K-ATPase and inhibit its hydrolytic activity10. However 
the amilospheroids are not formed at the early stages of AD, and cannot be the cause of Na,K-ATPase inhibition 
at these stages of disease. We have hypothesize that the monomeric Aβ can directly interact with Na,K-ATPase 
and regulate its activity.
In this study using isothermal titration calorimetry we have shown that Aβ (1-42) and Na,K-ATPase form 
equimolar complex with the dissociation constant (Kd) 3 μ M. We have found that the Na,K-ATPase:Aβ (1-42) 
complex formation leads to the dose-dependent loss of hydrolytic activity of the enzyme in solution and in neu-
roblastoma cells SH-SY5Y. Treatment of these cells with Aβ (1-42) also leads to a decrease of Na,K-ATPase trans-
port activity and Src-kinase activation in the first 30 min of incubation. Using fluorescently-labeled Aβ (1-42) we 
further show that amyloid peptide does not penetrate into cells within this time period. Hence, Aβ (1-42) directly 
interacts with the extracellular part of Na,K-ATPase and modulates its function. We have built a model of the Aβ 
(1-42):Na,K-ATPase complex, according to which binding of Aβ (1-42) occurs in the “gap” between the alpha- and 
beta-subunits, disrupting the function of Na,K-ATPase.
Results
Aβ(1-42) interacts with Na,K-ATPase and inhibits its hydrolytic activity in solution. We used 
purified preparation of Na,K-ATPase from duck salt glands with high Na,K-ATPase-specific activity which is 
difficult to achieve when purifying Na,K-ATPase from other tissues11. The protein from duck is a homolog of the 
Na,K-ATPase α 1β 1 isozyme from human tissues. A typical set of isothermal titration calorimetry (ITC) data for 
Aβ (1-42) binding to Na,K-ATPase at 25 °C is shown in Fig. 1A. Titration curve was well fitted to a model with 
one Aβ (1-42) binding site per Na,K-ATPase molecule. Complex formation between Na,K-ATPase and Aβ (1-42) 
was characterized by the following parameters: dissociation constant (Kd) 3 ± 1 μ M, enthalpy variation (Δ H) − 
13.2 ± 2.0 kcal/mole and the entropy contribution to binding (TΔ S) − 5.8 ± 1.2 kcal/mole. These thermodynamic 
parameters indicate that the binding is enthalpy-driven and is largely caused by electrostatic interactions12. The 
shape of ITC curve allowed to obtain the stoichiometry (N) of Aβ (1-42) binding to Na,K-ATPase equal to 1.1, 
which demonstrates that Aβ (1-42) is in the monomeric state.
Aβ (1-42) binding to Na,K-ATPase leads to the tremendous reduction of the enzyme hydrolytic activity in 
the dose-dependent manner (Fig. 1B). At 40 μ M Aβ (1-42) almost fully inhibits the ability of Na,K-ATPase to 
hydrolyze ATP.
The Aβ (1-42) concentration resulting in the enzyme losing half of its hydrolytic activity (IC50) is 24 ± 1 μM. 
The difference between Kd value obtained by ITC and the IC50 value can be attributed to the presence of ade-
nine nucleotides in the medium during hydrolytic activity measurements. Similar difference between the Kd and 
IC50 values is observed for Na,K-ATPase when it interacts with various cardiotonic steroids13. Dilution of the 
enzyme solution containing 40 μ M of Aβ (1-42) down to 10 μ M leads to recovery of the Na,K-ATPase activity 
(Supplementary Figure S1) suggesting that the enzyme inhibition is reversible.
Aβ(1-42) inhibits hydrolytic and transport activity of Na,K-ATPase in neuroblastoma cells. The 
inhibitory action of Aβ (1-42) on Na,K-ATPase was verified using neuroblastoma cells SH-SY5Y. The cells were 
incubated in the presence of Aβ (1-42) for 30 min. Then cells were lysed and hydrolytic activity of Na,K-ATPase in 
the lysates was measured (Fig. 2A). At concentration of Aβ (1-42) 40 μ M inhibition of the enzyme activity reached 
95% and the IC50 value is equal 4 ± 2 μ M which correlates well with the data on the inhibition of the purified 
Na,K-ATPase preparation (Fig. 1B).
Transport activity of Na-K-ATPase was evaluated in intact cells using 86Rb as a radioactive tracer for K+. 
Pre-treatment by 10 μ M Aβ (1-42) with or without 100 μ M ouabain was followed by the addition of 86Rb+ to the 
cells (see Methods). As shown in Fig. 2B, total K+ influx in the cells treated with Aβ (1-42) was suppressed by 36% 
compared to the control values. Whereas active K+ influx, caused by Na,K-ATPase activity, was suppressed by 
65%, the passive ouabain insensitive component (passive K+ influx) was unaltered by Aβ (1-42). Thus, introduc-
tion of Aβ (1-42) to the extracellular medium resulted in the inhibition of Na,K-ATPase transport activity in the 
cell.
Effect of Aβ(1-42) on cell viability. Parameters characterizing viability of SH-SY5Y cells after 30 min incu-
bation with Aβ (1-42) have been assessed by flow cytometry (percentage of apoptotic cells, cells with damaged 
membrane, the mitochondrial potential and level of intracellular calcium) and with xCelligence system allowing 
to evaluate the surface area occupied by cells on the plate. In the presence of 40 μ M of Aβ (1-42) for 30 min, cell 
size was dramatically reduced (Supplementary Figure S2), the level of intracellular calcium fell by 71 ± 1%, how-
ever other parameters of cell viability remained unchanged (Supplementary Figures S3 and S4). This indicated 
that the cells were alive but ion homeostasis and osmoregulation were disrupted. At a concentration of 10 μ M Aβ 
(1-42) did not affect the size and granularity of cells and the parameters of their viability after 30 min of incu-
bation (Supplementary Figures S3 and S4). Differences in cell proliferation in the presence of 10 μ M Aβ (1-42) 
became visible only after 15 h of incubation (Supplementary Figure S5).
Aβ(1-42) penetration in neuroblastoma cells. The ability of Aβ (1-42) to penetrate the SH-SY5Y cells 
was tested as they were treated by 10 μ M of Aβ (1-42), labeled with fluorescein (fluorescein-Aβ (1-42)). We used 
trypan blue for quenching the extracellular peptide fluorescence14. Changes in the cell fluorescence intensity 
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representing the amount of fluorescein-Aβ (1-42) bound to the cell surface and/or penetrated into the cells, rel-
ative to incubation time are presented in Fig. 3A. The fluorescence intensity of cells rises within one hour after 
treatment by fluorescein-Aβ (1-42). In the presence of trypan blue this fluorescence is almost totally quenched, 
i.e. fluorescein-Aβ (1-42) is located on the cell surface and does not penetrate into cells (Fig. 3B). Decrease in 
the effect of fluorescence quenching is observed initially after 4-hour incubation, indicating that the peptide 
has partially penetrated into cells and is no longer accessible for trypan blue (Fig. 3B). After 19 hours of the cells 
incubation with fluorescein-Aβ (1-42), fluorescence quenching by trypan blue is no longer observed, indicating 
intracellular location for the whole peptide sample labeled with fluorescein.
Structure of the Aβ(1-42):Na,K-ATPase complex. Model of the Aβ (1-42):Na,K-ATPase complex has 
been built using the shark Na,K-ATPase crystal structure (PDB code 2zxe) and Aβ (1-42) modeled structure. 
In all 9 top models of the complex generated by docking15, Aβ (1-42) was localized within the same binding site 
between the extracellular parts of the alpha- and beta-subunits of Na,K-ATPase (Supplementary Figure S6). The 
best score model is shown in Fig. 4. Pro125, Glu909, and Arg979 of the alpha-subunit and Glu88, Ser101, Glu273 
and Arg292 of the beta-subunit form hydrogen and ionic bonds with Aβ (1-42) (Supplementary Figure S7). 
Electrostatic interactions in the Aβ (1-42)-Na,K-ATPase interface are in agreement with the enthalpy changes 
Figure 1. Interaction of Aβ(1-42) with Na,K-ATPase in solution. (A) ITC titration curve (upper panel) and 
binding isotherm (lower panel) for Aβ (1-42) interaction with Na,K-ATPase at 25 °C. (B) Dependence of Na,K-
ATPase hydrolytic activity on Aβ (1-42) concentration. Enzyme activity without Aβ (1-42) is accepted as 100%.
www.nature.com/scientificreports/
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observed by ITC when the complex is formed. Aβ (1-42) residues are in close proximity (distance < 4.5 Å) of 
amino acid residues in the alpha and beta subunits (Supplementary Figure S7).
Activation of Src-kinase by Aβ(1-42). It is known that Na,K-ATPase interacts with Src-kinase to form 
a receptor complex16. To reveal the effect of Aβ (1-42) on receptor function of Na,K-ATPase, we have incubated 
SH-SY5Y cells with 10 μ M of Aβ (1-42) for 30 min and measured the level of phosphorylation of the Src-kinase 
residue Tyr416. Autophosphorylation of Tyr416, which leads to activation of Src-kinase, was described for 
Src-kinase dissociation from the complex with Na,K-ATPase when binding ouabain16. We have found that incu-
bation with Aβ (1-42) leads to an over 30% increase of phosphorylation level of the Src-kinase residue Tyr416 
(Fig. 5). Thus binding of Aβ (1-42) to Na, K-ATPase, by analogy with ouabain leads to the activation of Src-kinase.
Discussion
Decrease of Na,K-ATPase activity is one of the early markers of AD2,17-20. Na,K-ATPase plays a key role in main-
taining ion balance and resting potential and hence is important for the regulation of neuronal excitability, and 
synaptic transmission. It is also involved in memory formation, possibly due to the effect on synaptic plasticity 
of neurons and long-term potentiation3,5. There are numerous data indicating that the decrease in activity of 
Na,K-ATPase is not a consequence of neurodegenerative processes but, on the contrary, precedes them and 
causes the disruption of neuronal activity, deregulation of cellular ion homeostasis, calcium overload and neu-
ronal death2,3,5,17,21,22. On the other hand, there exists evidence that Aβ is required for the regulation of synaptic 
transmission7. We hypothesized that the physiological role of Aβ may involve regulation of the receptor and 
transport functions of Na,K-ATPase.
We have shown that Aβ (1-42) formed an equimolar complex with Na,K-ATPase that was unable to cleave ATP 
and transport ions (Figs 1 and 2). Inhibition of the Na,K-ATPase function in intact cells by Aβ (1-42) occurred 
within 30 minutes (Fig. 2B), whereas penetration of the Aβ (1-42) into the cells could be detected much later in 
time (Fig. 3). This observation suggested that the inhibitory effect is mediated by binding of the Aβ (1-42) to 
the extracellular domain of the enzyme. In line with these data, the model of the Aβ (1-42):Na,K-ATPase com-
plex (Fig. 4) implied binding of the peptide to the extracellular part of Na,K-ATPase, in the “gap” between the 
alpha- and beta- subunits. According to our model, binding Aβ (1-42) hinders the movement of the alpha- and 
beta-subunit towards each other during the catalytic cycle23, disrupting the Na,K-ATPase function. Hence Aβ is a 
Figure 2. Effect of Aβ(1-42) on transport and hydrolytic activity of Na,K-ATPase in SH-SY5Y cells. 
(A) Hydrolytic activity of Na,K-ATPase after 30 min treatment of cells with different concentrations of Aβ (1-42). 
(B) K+(86Rb) influx (active influx reflects transport activity of Na,K-ATPase) in SH-SY5Y cells after 30 min 
treatment with 10 μ M Aβ (1-42). Data are mean values for 4 independent experiments ± SE, *p < 0.04.
www.nature.com/scientificreports/
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potential physiological endogenic regulator of Na,K-ATPase. Observed acute effects cannot be directly translated 
to the pathogenesis of Alzheimer’s disease associated with chronic effects of the Aβ .
The cardiotonic steroids (CTS) are known as endogenous regulators of Na,K-ATPase, which bind to the extra-
cellular enzyme domains affecting its activity and receptor function24,25. Kd value for the Aβ (1-42) complex with 
Na,K-ATPase (3 μ M) is close to the Kd for complexes of Na,K-ATPase with such CTS as ouabain (0.8 μ M) and 
marinobufagenin (1.5 μ M) at the same conditions26. CTS and Aβ are present in the blood plasma in similar con-
centrations, within several nanomoles27. Taking into account that binding of CTS to Na,K-ATPase triggers acti-
vation of Src-kinase28, it is reasonable to suggest that binding of Aβ to Na,K-ATPase may also cause the activation 
of the Src signaling pathway. Indeed, we have shown that incubation of neuroblastoma cells with Ab, leading to 
decrease of Na,K-ATPase activity, causes the activation of Src-kinase (Fig. 5). Previously, it was shown that treat-
ment of neuronal cells by Aβ (1-42) leads to phosphorylation of a number of proteins within 10 minutes, and that 
this phosphorylation was blocked by addition of the Src family tyrosine kinase inhibitor29. Thus, it is tempting 
to suggest that physiological function of CTS and Aβ as signaling entities, as well as toxicity of abnormally high 
doses of both messengers, may share certain molecular mechanisms.
Endogenous CTS level varies in different pathologies, including ischemia30 and hypertension24, leading to the 
modulation of Na,K-ATPase activity and launching several signaling cascades in cells. There is only limited data 
on the causes of changes in the physiological levels of Aβ . It has been shown that the level of Aβ rises during stress 
Figure 3. Penetration of fluorescein-Aβ(1-42) into SH-SY5Y cells. (A) Distribution of cells according to 
the intensity of green fluorescence after 30 min, 1 h and 19 h incubation with Aβ (1-42) labeled with fluorescein 
(Aβ -F) before (upper panels) and after (lower panels) addition of trypane blue (TB). (B) Quenching of cell 
fluorescence by trypane blue versus time of treatment by Aβ -F.
www.nature.com/scientificreports/
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due to the increase of APP processing31. It also rises upon the changes in hormonal status, particularly in the level 
of luteinizing hormone and testosterone32, and as a result of injuries33. Short-term reduction in Na,K-ATPase 
activity may allow cells to maintain the ATP pool and promote their viability11. Thus, short-term increase in the 
level of Aβ in the extracellular space and subsequent binding of Aβ to Na,K-ATPase would allow to regulate the 
activity of neuronal Na,K-ATPase under pathological conditions. Binding of Aβ would induce a number of signa-
ling cascades increasing the adaptive capacity of the cells. As we have shown Aβ (1-42) in the 10 μ M concentration 
decreases transport activity in the intact cells by 65% (Fig. 2), but has no toxic effect on cells in short incubation 
periods (Supplementary Figures S3 and S4) though it causes Src-kinase activation (Fig. 5). Even at the Aβ (1-42) 
concentration 40 μ M, which completely inactivates Na,K-ATPase, the fraction of dead neuroblastoma cells in 
the population did not increase, although a disruption of ionic homeostasis and osmoregulation was observed 
(Supplementary Figures S2–S4). Exposure to Aβ (1-42) for longer periods of time led to the loss of viability of 
SH-SY5Y cells (Supplementary Figure S5), and, as we showed earlier, of the human differentiated neuronal cells9 
and neuroblastoma cells SK-N-SH34. Hence, disruption of the Aβ homeostasis leading to a prolonged increase in 
Aβ local concentrations, e.g. in the synaptic cleft, will lead to the inhibition of Na,K-ATPase, imbalance of the Na+ 
and Ca2+ levels and the loss of neuronal excitability. Local concentrations of the peptide can vary widely and must 
reach high values before the aggregates and β -amyloid plaques will form. It was shown that at 1 nM concentration 
of Aβ (1-42) in the extracellular fluid, its accumulation was observed in endosomes/vesicles of SH-SY5Y cells after 
24 h incubation35. At the concentration of 25 nM in extracellular fluid, the Aβ (1-42) concentration in vesicles con-
stituted over 2.5 μ M after 24 h incubation, i.e. a similar concentration was also reached at the cell surface35. These 
data imply that impaired homeostasis of β -amyloid will lead to its accumulation at cell surface creating high local 
concentrations of the peptide in the area of Na,K-ATPase localization even at the nanomolar concentrations of 
Aβ (1-42) in extracellular fluid. This is consistent with the hypothesis that disruption of the electrotonic properties 
of neurons observed in AD is a direct consequence of the long-term inhibition of Na,K-ATPase at early stages 
of the disease. Additionally, beta-subunit of the enzyme is involved in intercellular adhesion36, and Aβ binding 
to the extracellular part of Na,K-ATPase may lead to disruption of these contacts and to neuronal degeneration.
To summarize, we have shown that the monomeric Aβ (1-42) forms equimolar complex with the 
Na,K-ATPase, leading to acute inhibition of the enzyme transport and hydrolytic functions. Formation of 
Ab-ATPase complexes is therefore of high physiological importance. For example, short-term increase of Aβ 
(1-42) level under stress conditions31–33 will lead to reversible inhibition of Na,K-ATPase which could prevent 
Figure 4. The model of Aβ(1-42):Na,K-ATPase complex. 3D model of the complex constructed on the basis 
of shark Na,K-ATPase α 1β 1 isozyme (PDB code 2zxe). The modeled Aβ (1-42) was docked to the protein  
using VinaAutoDock program15 (for details see Methods). Na,K-ATPase α -subunit is represented in gray,  
β -subunit in red, γ -subunit in blue. Aβ (1-42) is shown as translucent green molecular surface. Cell membrane 
is represented in translucent light green.
www.nature.com/scientificreports/
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ATP depletion and increasing cell viability. We have demonstrated that acute suppression of the Na,K-ATPase in 
intact neuroblastoma cells SH-SY5Y by Aβ (1-42) is caused by binding of the peptide to the extracellular part of 
the protein. Activation of Src-kinase in neuroblastoma cells indicates that Aβ (1-42) is a potential activator of the 
Na,K-ATPase-mediated signal transduction. Our data contribute to the understanding of the physiological role 
of Aβ , acting as a regulator of the functional activity of Na,K-ATPase.
Methods
Na,K-ATPase and Aβ(1-42) preparations. Synthetic peptide Aβ (1-42): [H2N]-DAEFRHDSGYEVHH
QKLVFFAEDVGSNKGAIIGLMVGGVVIA-[COOH] was purchased from Biopeptide. Preparation of the mon-
omeric form of Aβ (1-42) was performed as described elsewhere37. To do this, cold hexafluoroisopropanol (Fluka) 
was added to dry Aβ (1-42) to a concentration of 1 mM and incubated for 60 min at room temperature. Then this 
solution was put on ice for 10 min and aliquoted into non-siliconized microcentrifuge tubes (0.56 mg peptide 
per tube). Peptide in the tubes was dried under vacuum using Eppendorf Concentrator 5301. Dried peptide 
was stored at − 80 °C. 2.5 mM peptide stock solution was prepared by adding 20 μ L of 100% anhydrous DMSO 
(Sigma-Aldrich) to 0.22 mg peptide and incubating for 1 h at room temperature. For use in the experiments, the 
peptide was diluted to the required concentration with buffer solution. Equivalent amount of DMSO was added 
to the control samples in all experiments. Only freshly prepared peptide solutions were used for all experiments. 
By dynamic light scattering (DLS) and turbidity methods it was shown that there were no aggregates and higher 
molecular weight oligomers in Aβ (1-42) preparation (40 μ M) after 1 hour following preparation of the water 
solution. To determine the turbidity the optical density at 405 nm of freshly prepared solutions of Aβ (1-42) was 
recorded on Jasco V-560 spectrophotometer within one hour. The absorbance of the solution does not change, 
which allows to make a conclusion about the absence of particles in solution with a size of 1–100 nm. DLS method 
allows measuring the particle size from 0.6 to 10 nm. The DLS measurements were carried out on a Zetasizer 
Nano ZS apparatus (Malvern Instruments Ltd.). According to our data the freshly prepared solution of amyloid 
(40 μ M) does not contain particles in this size range.
The monomer and low molecular weight oligomer quantities in Aβ (1-42) solution were estimated by 
SDS-PAGE with pre-stabilization of oligomers by photoinduced crosslinking using covalent Tris (2,2-bipyridyl) 
dichlororuthenium (II) hexahydrate38. The monomers constituted 80% in Aβ (1-42) preparation (Supplementary 
Figure S8).
Figure 5. Activation of Src-kinase by Aβ(1-42). After 30 min of incubation with 10 μ M Aβ (1-42) SH-SY5Y 
cells were lysed, and isolated proteins were separated by SDS-PAGE and probed in a Western blot by antibodies 
against total Src-kinase (Src) or phosphorylated Y416 Src-kinase (pY416 Src). Bars represent the changes in 
phosphorylation of Src-kinase normalized by its total amount (pY416 Src/Src). n = 3, mean ± SD; * p < 0.05. 
Shown above are the original immunoblotting readouts.
www.nature.com/scientificreports/
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Purified preparation of Na,K-ATPase (α 1β 1 isozyme) was obtained from duck salt glands as described else-
where11,39. The purity grade of Na,K-ATPase was 99% (Supplementary Figure S9) and specific activity of the 
enzyme reached ~2400 μ mol of Pi (mg of protein × h)−1 at 37 °C.
Cell culture. Undifferentiated human neuroblastoma SH-SY5Y cells were cultured in DMEM/F-12 media, 
containing 20% fetal bovine serum (FBS), 0.2 mg/ml Penicillin-Streptomycin, and 0.01 mM sodium pyruvate 
on uncoated petri dishes at 37 °C in humid atmosphere with 5% CO2. Notably, non-differentiated SH-SY5Y 
cells are a ubiquitous model frequently used to study mechanism of the Аβ (1-42) effects on cells35,40. Amount 
of Na,K-ATPase at the SH-SY5Y cell surface was close to the amount present at the surface of primary neuronal 
granular cells, as confirmed be similar values of Na,K-ATPase transport activity in these cells (active K+ influx 
0.40 mM/(mg × h) for SH-SY5Y cells, Figure 2B, versus 0.35 mM/(mg × h) for primary neurons41). Cell lysates 
containing Na,K-ATPase were prepared by repeated freezing-thawing cycles41.
Hydrolytic and transport Na,K-ATPase activity measurements. Hydrolytic activity of Na,K-ATPase 
in the purified preparation and in cell lysates was measured as ouabain-sensitive (1 mM) ATP cleavage in the 
medium containing 130 mM NaCl, 20 mM KCl, 3 mM MgCl2, 3 mM ATP, and 30 mM imidazole, pH 7.4, 37 °C as 
described in41-43.
Transport activity of the enzyme was measured in a separate set of experiments in intact cells using 86Rb as 
a radioactive tracer for K+. Ouabain-sensitive unidirectional K+(86Rb) influx was measured on the Petri dishes 
(diameter 3 cm) containing Tyrode solution. To distinguish between the active, Na,K-ATPase-mediated, and pas-
sive K+ influx, ouabain at the final concentration of 100 μ M was added to one-half of the samples 15 min before 
the addition of the radioactive tracer. Aβ (1-42) was added 10 min before introduction of the radioactive tracer. 
Flux measurements were started by adding 86RbCl (~0.5 μ Ci/ml cell suspension; Perkin-Elmer). After 10–60 min 
of incubation with 86Rb, flux was stopped by immediate dilution with 10 ml ice-cold washing medium (100 mM 
Mg(NO3)2 and 10 mM imidazole, pH 7.4, 4 °C). After additional washing from external 86Rb cells were lysed in 5% 
TCA. Radioactivity of cells and incubation medium was measured using a Tri-Carb 1600 TR liquid scintillation 
counter (Packard) in water phase (Cherenkov effect). Accumulation of 86Rb+ by the neuroblastoma cells was lin-
ear within at least 30 min incubation with the tracer. Uptake over this time interval was used for the calculations 
of the unidirectional K+ influx. Unidirectional fluxes (J) were calculated using the following equation: J = (Ac/Am 
[K+]e)/tmprotein, where Ac and Am are radioactivity of cells in 1 ml suspension and 1 ml medium, respectively; 
mprotein is the amount of protein (mg/ml cell suspension) corrected for the amount of viable cells in suspension, 
[K+]e is K+ concentration in the incubation medium, and t is the equilibration time with the tracer.
Isothermal titration calorimetry (ITC). The thermodynamic parameters of Aβ (1-42) binding to 
Na,K-ATPase were measured using a MicroCal iTC200 instrument, as described elsewhere44,45. Experiments 
were carried out at 25 °C in 10 мМ imidazole buffer (pH 7.5), containing 130 мМ NaCl, 30 мM KCl, 3 мМ MgCl2. 
Aliquots (2.6 μ l) of ligands were injected into a 0.2-ml cell containing protein solution to achieve a complete 
binding isotherm. Protein concentration in the cell ranged from 5 to 20 μ M, and ligand concentration in the 
syringe ranged from 50 to 200 μ M. The resulting titration curves were fitted using the MicroCal Origin software, 
assuming one set of binding sites. Affinity constants (Ka), enthalpy variations (Δ H) and stoichiometry of binding 
(N) were determined and the Gibbs energy (Δ G) and entropy variations (Δ S) were calculated from the equation: 
Δ G = −RTlnKa = Δ H-TΔ S.
Aβ(1-42) labeling and monitoring its penetration into cells. Aβ (1-42) was labeled by NHS495 dye 
(amine-reactive derivative of fluorescein, Eex/Eem = 488/535 нм). Six microliters of Aβ (1-42) (2.5 mM) mixed 
with 15 μ l of NHS495 (1 mM) were incubated one hour at room temperature. To remove the unreacted “free” 
dye the volume of reaction mixture was adjusted to 500 μ L by phosphate buffer, pH 7.4 and then passed through 
desalting column PD MidiTrap G-25 (GE Healthcare). Labeled Aβ (1-42) was added to the cell suspension at a 
concentration of 10 μ M. Penetration of Aβ (1-42) into cells was evaluated by flow cytometry on GALLIOS flow 
cytometer (Beckman Coulter). The distinction between internalized and surface-bound fluorescein-Aβ (1-42) 
was performed using trypan blue (1.2 mg/ml) for quenching surface-bound fluorescence as described in14. The 
fluorescence of living cells was assessed after 10, 30, 60, 120, 180 min and 19 h with or without trypan blue.
Flow cytometry. Analysis of the cells was performed on GALLIOS flow cytometer (BeckmanCoulter). In 
our analysis we have excluded cell debris lying outside the gate R1 (Supplementary Figure S2). The size of the cells 
was assessed by forward side scatter (FS). Cells with damaged membrane were determined according to staining 
with propidium iodide (PI) (Sigma) (Ex/Em = 535/617 nm). Mitochondrial membrane potential in intact cells 
(Ψ ) was detected by MitoProbe DilC1(5) (Ex/Em = 638/658 nm) (Invitrogen), according to Mironova et al.46. 
The Ca2+ level in intact cells was estimated by staining with fluo-4 (Ex/Em 494/516 nm) (Molecular Probes), 
according to Mitkevich et al.47. Each value is the mean of at least three independent experiments with triplicate 
samples ± SD.
Immunoblot analysis. Cells were incubated with 10 μ M Aβ (1-42) for 30 min and then lysed in the RIPA 
buffer (25 mM tris-HCl, pH 7.6, 150 mМ NaCl, 1% Nonidet-P40, 0.1% SDS, 1% sodium deoxycholate) con-
taining 1 μ M of PMSF with stirring at 4 °C for 1 h. The probes were then centrifuged at 13000 g for 10 min and 
the supernatant was collected. Proteins of cell lysates were separated on SDS-PAGE and transferred to a PVDF 
membrane. After membrane blocking in 5% nonfat milk in PBST, the detection of phospho (Tyr 416) Src and 
total Src was carried out by incubating the membrane in the solution of appropriate rabbit polyclonal antibodies 
(both from Cell Signaling Technology) in PBST. The level of β -actin was also estimated using mouse monoclonal 
anti-β -actin antibody (Ambion). Visualization of the proteins was performed by the appropriate horseradish 
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peroxidase-conjugated secondary antibodies provided by the enhanced chemiluminescence SuperSignal ™ West 
Femto Maximum Sensitivity Substrate kit (ThermoScientific). Chemiluminescence was detected using Bio-Rad 
ChemiDoc MP instrument. Densitometric analysis was performed with Image Lab program (Bio-Rad) and the 
results were expressed as ratio of phospho-Src to total Src band intensity (phospho-Src/Src).
Statistical analysis. The comparison of data groups was performed using Student’s t-test; p < 0.05 was 
considered significant. ITC, hydrolytic activity and flow cytometry data are presented as means of at least 
three independent experiments ± SD. Data of K+(86Rb) influx are presented as means of four independent 
experiments ± SE.
Modeling of the structure of Aβ(1-42):Na,K-ATPase complex. Model of the Aβ (1-42) peptide was 
constructed using as templates the Aβ (1-16) structures 1ze7 and 4f37 (PDB ids) and the ab initio model of Aβ 
(1-42) built using the server Bhageerath48. The resulting model of Aβ (1-42) was minimized in the AMBER99 
force field with the MOE program version 2013.08. Modeling of the Aβ (1-42):Na,K-ATPase complex was per-
formed using the structure of Na,K-ATPase from shark glands 2zxe (PDB id) solved at 2.4 Å resolution49, and the 
modeled structure of Aβ (1-42). Docking has been carried out with VinaAutoDock program15, and the docking 
was constrained to cover only the extracellular part of the protein.
Determination of Cell index. Analysis was performed on xCELLigence real time cell analyser (RTCA) 
(ACEA Biosciences) measures focal adhesion of living cells in real-time50. Cells were seeded onto custom RTCA 
E-plates (ACEA Biosciences) coated with high-density gold arrays for measuring electrical impedance. The 
xCELLigence biosensor measures cellular adhesion, which is converted to Cell index (unit less) by the xCELLi-
gence software (version 1.2.1). Cells were seeded into E16 well plates and allowed to recover until the cells had 
attained a stable Cell index. Treatment of cells on the plates with Aβ (1-42) was performed in serum free DMEM. 
After 4 h of treatment inactivated FBS (10%) was added into plates.
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